Abstract
We evaluated whether discontinuation of platelet therapy (APT) before noncardiac surgery (NCS) was associated with higher net adverse clinical event (NACE) in patients with DES. Among 23358 DES-treated patients, 2269 patients were required NCS after DES implantation. NACE was compared with use of
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
